Published in Virology on February 01, 1971
Susceptibility of mammalian (hamster) cell culture to infection with herpesvirus of turkeys. Appl Microbiol (1972) 0.84
Development of an equine herpesvirus in two cell culture systems: light and electron microscopy. Infect Immun (1972) 0.82
DNA configuration in the core of Marek's disease virus. J Virol (1974) 0.82
Subcellular distribution and life cycle of Epstein-Barr virus in keratinocytes of oral hairy leukoplakia. Am J Pathol (1991) 0.79
Mechanism of intranuclear crystal formation of herpes simplex virus as revealed by the negative staining of thin sections. J Virol (1971) 0.78
The ultrastructure of lymphoblastoid cell lines from Marek's disease lymphomata. Br J Cancer (1975) 0.78
Use of Japanese quail embryo fibroblast cells for propagation and assay of turkey herpesvirus FC-126. Appl Microbiol (1974) 0.77
Ultrastructure of hamster kidney cell culture infected with Herpesvirus. Infect Immun (1974) 0.75
Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Biochemistry (1976) 2.75
Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis (1970) 2.68
Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res (1970) 2.58
Studies on the etiology of Marek's disease. II. Finding of a herpesvirus in cell culture. Proc Soc Exp Biol Med (1968) 2.40
Specific integration of REV proviruses in avian bursal lymphomas. Nature (1981) 2.11
Size and composition of Marek's disease virus deoxyribonucleic acid. J Virol (1971) 2.10
A new group of oncogenic viruses: reticuloendotheliosis, chick syncytial, duck infectious anemia, and spleen necrosis viruses. J Natl Cancer Inst (1973) 2.03
Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture. Proc Soc Exp Biol Med (1968) 1.97
Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate. Antimicrob Agents Chemother (1978) 1.84
Characterization of bacteriophage gh-1 for Pseudomonas putida. J Bacteriol (1966) 1.70
The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc Natl Acad Sci U S A (2000) 1.55
Pathogenesis of avian lymphoid leukosis. I. Histogenesis. J Natl Cancer Inst (1968) 1.54
The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A (1985) 1.50
Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell (1981) 1.49
Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J Virol (1985) 1.49
Cell-free transmission and in vivo replication of Marek's disease virus. J Virol (1970) 1.48
Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. J Virol (1997) 1.43
Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpesvirus. Virology (1984) 1.40
Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. J Virol (1998) 1.39
Cell culture techniques for primary isolation of Marek's disease-associated herpesvirus. Avian Dis (1969) 1.37
Occurrence of avian leukosis virus subgroup J in commercial layer flocks in China. Avian Pathol (2004) 1.35
Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol (2001) 1.34
Demonstration of a tumor-associated surface antigen in Marek's disease. J Immunol (1975) 1.31
Low oncogenic potential of avian endogenous RNA tumor virus infection or expression. J Natl Cancer Inst (1975) 1.31
Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci U S A (2004) 1.30
Marek's disease herpesvirus-induced DNA polymerase. J Virol (1974) 1.29
Oncogenicity of avian leukosis viruses of different subgroups and of mutants of sarcoma viruses. Infect Immun (1977) 1.29
Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J Virol (1991) 1.26
Electron microscopy of a herpes virus associated with the agent of Marek's disease in cell culture. Cancer Res (1968) 1.25
Low incidence of lymphoid tumors in chickens continuously producing endogenous virus. Avian Dis (1980) 1.19
The reticuloendotheliosis viruses. Curr Top Microbiol Immunol (1975) 1.18
Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J Immunol (1983) 1.17
Pathogenicity and Antigenicity of Clones from Strains of Marek's Disease Virus and the Herpesvirus of Turkeys. Infect Immun (1971) 1.16
Relationships among visceral lymphomatosis, bursa of Fabricius, and bursa-dependent lymphoid tissue of the chicken. J Natl Cancer Inst (1966) 1.16
Gene insertion into the chicken germ line by retroviruses. Poult Sci (1986) 1.13
Deoxyribonucleic acid of Marek's disease virus in a lymphoblastoid cell line from Marek's disease tumours. J Gen Virol (1974) 1.13
Genetic mapping of quantitative trait loci affecting susceptibility to Marek's disease virus induced tumors in F2 intercross chickens. Genetics (1998) 1.09
B-haplotype influence on Marek's disease, Rous sarcoma, and lymphoid leukosis virus-induced tumors in chickens. Poult Sci (1981) 1.09
Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen. J Virol (1983) 1.09
Nucleotide and predicted amino acid sequences of Marek's disease virus homologues of herpes simplex virus major tegument proteins. J Gen Virol (1993) 1.08
Responses of cell cultures from various avian species to Marek's disease virus and herpesvirus of turkeys. Am J Vet Res (1971) 1.08
Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis (1983) 1.07
Clinical panel assessment of photodamaged skin treated with isotretinoin using photographs. Arch Dermatol (1992) 1.07
Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease. Avian Dis (1972) 1.07
Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins. Virus Genes (1990) 1.07
Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis (1982) 1.06
A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Avian Dis (1977) 1.06
Attenuation of Marek's disease virus and study of its properties in two different cell cultures. J Natl Cancer Inst (1970) 1.06
A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res (2011) 1.06
Serologic differences among nondefective reticuloendotheliosis viruses. Arch Virol (1987) 1.05
Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J Immunol (1978) 1.05
MEQ and V-IL8: cellular genes in disguise? Acta Virol (2000) 1.03
Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys. Proc Natl Acad Sci U S A (1984) 1.03
Pathogenesis of avian lymphoid leukosis. II. Immunologic reactivity during lymphomagenesis. J Natl Cancer Inst (1968) 1.02
Long-term studies of Marek's disease infection in individual chickens. Avian Dis (1971) 1.02
Lymphomas resembling lymphoid leukosis in chickens inoculated with reticuloendotheliosis virus. Int J Cancer (1979) 1.01
In vitro assay of mitogen stimulation of avian peripheral lymphocytes. Avian Dis (1975) 1.01
Marek's disease herpes virus: a cytomegalovirus. Proc Natl Acad Sci U S A (1969) 1.00
Evidence for a herpesvirus as an etiologic agent of marek's disease. Avian Dis (1969) 1.00
Letter: Preparation of (R)- and (S)-mevalonic acids. J Am Chem Soc (1975) 0.99
Transmission of Marek's disease with oral washings and feces from infected chickens. Proc Soc Exp Biol Med (1967) 0.98
Effect of phosphonoacetate on Marek's disease virus replication. J Natl Cancer Inst (1976) 0.98
Meq: an MDV-specific bZIP transactivator with transforming properties. Curr Top Microbiol Immunol (2001) 0.98
Preliminary studies on cell cultures infected with Marek's disease agent. Avian Dis (1968) 0.97
High resolution mapping and identification of new quantitative trait loci (QTL) affecting susceptibility to Marek's disease. Anim Genet (1999) 0.96
Development and characterization of monoclonal antibodies to subgroup J avian leukosis virus. Avian Dis (2002) 0.96
Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable Virus. J Natl Cancer Inst (1976) 0.96
Marek's disease lymphoma of chicken and its causative herpesvirus. Biochim Biophys Acta (1979) 0.96
Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas. J Gen Virol (1997) 0.96
Lymphoid neoplasms in chicken flocks free of infection with exogenous avian tumor viruses. J Natl Cancer Inst (1979) 0.96
Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1. Virology (1994) 0.95
Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother (1998) 0.95
Phenotypic mixing test to detect and assay avian leukosis viruses. Avian Dis (1975) 0.95
Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. Avian Dis (1997) 0.94